Gabapentin

CAS 60142-96-3 26 current records 4 historicalSmall Molecule

Who holds supplier records for Gabapentin? 26 organisations hold a current record for Gabapentin: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 20 of them hold a valid EU Certificate of Suitability (21 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (13), China (7), Italy (3), Netherlands (1) and 2 other countries (2).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Gabapentin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/gabapentin

Reading the evidence

  • 26 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 16 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (26)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Gabapentin. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Gabapentin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (21)

Certificates of Suitability on the EDQM register for Gabapentin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 30 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2022-228 - Rev 03
Gabapentin, Process-III
Jul 2026—
HIKAL LIMITED BengaluruIN
CEP 2013-055 - Rev 03
Gabapentin, Process II
Jul 2026Inspected Nov 2025
Switzerland
ZHEJIANG APELOA JIAYUAN PHARMACEUTICAL CO., LTD. DongyangCN
CEP 2025-644 - Rev 00
Gabapentin
Jul 2026—
ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO. LTD. TaizhouCN
CEP 2022-303 - Rev 01
Gabapentin, Site Yongtai Chiral
Mar 2026—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2011-185 - Rev 03
Gabapentin
Oct 2025—
HETERO DRUGS LIMITED HyderabadIN
CEP 2013-167 - Rev 04
Gabapentin
Sept 2025—
TAPI NL B.V. AmsterdamNL
CEP 2011-167 - Rev 03
Gabapentin
Jul 2025—
ANJAN DRUG PRIVATE LIMITED GummidipoondiIN
CEP 2013-164 - Rev 02
Gabapentin
Jun 2025—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2024-148 - Rev 01
Gabapentin, Process V
Jun 2025Inspected May 2026
Italy
ZHEJIANG BAMBOO PHARMACEUTICALS CO.,LTD. ShaoxingCN
CEP 2023-027 - Rev 02
Gabapentin
Apr 2025—
DIVI'S LABORATORIES LIMITED HyderabadIN
CEP 2019-200 - Rev 01
Gabapentin, Alternative process
Apr 2025—
JIANGXI SYNERGY PHARMACEUTICAL CO., LTD. YichunCN
CEP 2019-343 - Rev 03
Gabapentin, Process II
Apr 2025—
IOL CHEMICALS AND PHARMACEUTICALS LTD LudhianaIN
CEP 2022-188 - Rev 00
Gabapentin
Apr 2024—
ZHEJIANG CHIRAL MEDICINE CHEMICALS CO., LTD. HangzhouCN
CEP 2011-258 - Rev 01
Gabapentin
Jan 2024—
SOLARA ACTIVE PHARMA SCIENCES LIMITED ChennaiIN
CEP 2011-154 - Rev 03
Gabapentin
Sept 2023—
SARACA LABORATORIES LIMITED Gaddapotharam VillageIN
R1-CEP 2016-092 - Rev 00
Gabapentin
Apr 2022—
OLON S.P.A. RodanoIT
R1-CEP 2011-344 - Rev 01
Gabapentin
Jun 2021—
F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. Montecchio MaggioreIT
R1-CEP 2013-173 - Rev 00
Gabapentin
Aug 2019—
ERREGIERRE S.P.A. San Paolo D'ArgonIT
R1-CEP 2012-210 - Rev 00
Gabapentin
Sept 2018—
JIANGXI SYNERGY PHARMACEUTICAL CO., LTD. FengxinCN
R1-CEP 2011-264 - Rev 00
Gabapentin
Oct 2017—
Medichem, S.A. Sant Joan DespíES
R1-CEP 2011-225 - Rev 00
Gabapentin
Jul 2017—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Gabapentin are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • China · Inactive DMF 22015 · filed Sept 2008
  • Jiangsu Nhwa Pharmaceutical Co., Ltd.
    China · Inactive DMF 20645 · filed May 2007
  • SANDOZ INDUSTRIAL PRODUCTS SA
    Inactive DMF 18489 · filed Jul 2005
  • Italy · Inactive DMF 16342 · filed Dec 2002

Overview

Gabapentin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL940).

Chemical identity

IUPAC name
2-[1-(aminomethyl)cyclohexyl]acetic acid
Canonical SMILES
C1CCC(CC1)(CC(=O)O)CN
InChIKey
UGJMXCAKCUNAIE-UHFFFAOYSA-N
Synonyms
CI-945, DM-1796, Gabapentin, Gabapentina, Gabapentine, GOE 3450, GOE-3450, Gralise, Neurontin, NSC-742194, NSC-759254, 1-(Aminomethyl)cyclohexaneacetic acid

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Anti-epileptic Agent
Physiologic effect
Decreased Central Nervous System Disorganized Electrical Activity

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Gabapentin?

26 organisations hold an active US FDA Type II Drug Master File or a CEP for Gabapentin: Hetero Drugs Limited (India), Jiangxi Synergy Pharmaceutical Co., Ltd (China), ANJAN DRUG PRIVATE LTD (India), APITORIA PHARMA PRIVATE LTD (India), Divis Laboratories (India), FIS FABBRICA ITALIANA SINTETICI SPA (Italy), HIKAL LTD (India) and MATRIX PHARMACORP PRIVATE LTD (India), and 18 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Gabapentin Drug Master Files are active?

Hetero Drugs Limited (DMF 26131, 31819), Jiangxi Synergy Pharmaceutical Co., Ltd (DMF 25825, 34315), ANJAN DRUG PRIVATE LTD (DMF 22765), APITORIA PHARMA PRIVATE LTD (DMF 20122), Divis Laboratories (DMF 19000), FIS FABBRICA ITALIANA SINTETICI SPA (DMF 14024), HIKAL LTD (DMF 16060) and MATRIX PHARMACORP PRIVATE LTD (DMF 18225) and 15 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Gabapentin records mean?

4 organisations have only inactive Type II DMFs for Gabapentin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Gabapentin have a European Certificate of Suitability?

Yes. 20 organisations hold a valid CEP for Gabapentin on the EDQM register, including APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), HIKAL LIMITED Bengaluru (IN), ZHEJIANG APELOA JIAYUAN PHARMACEUTICAL CO., LTD. Dongyang (CN), ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO. LTD. Taizhou (CN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN) and HETERO DRUGS LIMITED Hyderabad (IN) and 15 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Gabapentin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Gabapentin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.